298 related articles for article (PubMed ID: 30987250)
1. The Influence of Curcumin on the Downregulation of MYC, Insulin and IGF-1 Receptors: A possible Mechanism Underlying the Anti-Growth and Anti-Migration in Chemoresistant Colorectal Cancer Cells.
Hosseini SA; Zand H; Cheraghpour M
Medicina (Kaunas); 2019 Apr; 55(4):. PubMed ID: 30987250
[No Abstract] [Full Text] [Related]
2. Esculetin enhances the inhibitory effect of 5-Fluorouracil on the proliferation, migration and epithelial-mesenchymal transition of colorectal cancer.
Yan L; Yu HH; Liu YS; Wang YS; Zhao WH
Cancer Biomark; 2019; 24(2):231-240. PubMed ID: 30689555
[TBL] [Abstract][Full Text] [Related]
3. Turmeric extract, with absorbable curcumin, has potent anti-metastatic effect in vitro and in vivo.
Li M; Yue GG; Tsui SK; Fung KP; Lau CB
Phytomedicine; 2018 Jul; 46():131-141. PubMed ID: 30097113
[TBL] [Abstract][Full Text] [Related]
4. Curcumin enhances the effects of 5-fluorouracil and oxaliplatin in mediating growth inhibition of colon cancer cells by modulating EGFR and IGF-1R.
Patel BB; Sengupta R; Qazi S; Vachhani H; Yu Y; Rishi AK; Majumdar AP
Int J Cancer; 2008 Jan; 122(2):267-73. PubMed ID: 17918158
[TBL] [Abstract][Full Text] [Related]
5. Bcl-2-associated athanogene 3(BAG3) is associated with tumor cell proliferation, migration, invasion and chemoresistance in colorectal cancer.
Li N; Chen M; Cao Y; Li H; Zhao J; Zhai Z; Ren F; Li K
BMC Cancer; 2018 Aug; 18(1):793. PubMed ID: 30081850
[TBL] [Abstract][Full Text] [Related]
6. Low curcumin concentration enhances the anticancer effect of 5-fluorouracil against colorectal cancer.
Zheng X; Yang X; Lin J; Song F; Shao Y
Phytomedicine; 2021 May; 85():153547. PubMed ID: 33812170
[TBL] [Abstract][Full Text] [Related]
7. Antitumor effects of curcumin on the proliferation, migration and apoptosis of human colorectal carcinoma HCT‑116 cells.
Xiang L; He B; Liu Q; Hu D; Liao W; Li R; Peng X; Wang Q; Zhao G
Oncol Rep; 2020 Nov; 44(5):1997-2008. PubMed ID: 33000266
[TBL] [Abstract][Full Text] [Related]
8. Combined treatment of curcumin and small molecule inhibitors suppresses proliferation of A549 and H1299 human non-small-cell lung cancer cells.
Lin HP; Kuo LK; Chuu CP
Phytother Res; 2012 Jan; 26(1):122-6. PubMed ID: 21567511
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-149 Increases the Sensitivity of Colorectal Cancer Cells to 5-Fluorouracil by Targeting Forkhead Box Transcription Factor FOXM1.
Liu X; Xie T; Mao X; Xue L; Chu X; Chen L
Cell Physiol Biochem; 2016; 39(2):617-29. PubMed ID: 27415661
[TBL] [Abstract][Full Text] [Related]
10. Curcumin mediates chemosensitization to 5-fluorouracil through miRNA-induced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer.
Toden S; Okugawa Y; Jascur T; Wodarz D; Komarova NL; Buhrmann C; Shakibaei M; Boland CR; Goel A
Carcinogenesis; 2015 Mar; 36(3):355-67. PubMed ID: 25653233
[TBL] [Abstract][Full Text] [Related]
11. Nuclear IGF-1R predicts chemotherapy and targeted therapy resistance in metastatic colorectal cancer.
Codony-Servat J; Cuatrecasas M; Asensio E; Montironi C; Martínez-Cardús A; Marín-Aguilera M; Horndler C; Martínez-Balibrea E; Rubini M; Jares P; Reig O; Victoria I; Gaba L; Martín-Richard M; Alonso V; Escudero P; Fernández-Martos C; Feliu J; Méndez JC; Méndez M; Gallego J; Salud A; Rojo F; Castells A; Prat A; Rosell R; García-Albéniz X; Camps J; Maurel J
Br J Cancer; 2017 Dec; 117(12):1777-1786. PubMed ID: 29123263
[TBL] [Abstract][Full Text] [Related]
12. The effectiveness of an anti-human IL-6 receptor monoclonal antibody combined with chemotherapy to target colon cancer stem-like cells.
Ying J; Tsujii M; Kondo J; Hayashi Y; Kato M; Akasaka T; Inoue T; Shiraishi E; Inoue T; Hiyama S; Tsujii Y; Maekawa A; Kawai S; Fujinaga T; Araki M; Shinzaki S; Watabe K; Nishida T; Iijima H; Takehara T
Int J Oncol; 2015 Apr; 46(4):1551-9. PubMed ID: 25625841
[TBL] [Abstract][Full Text] [Related]
13. Assessment of insulin-like growth factor 1 receptor as an oncogene in esophageal squamous cell carcinoma and its potential implication in chemotherapy.
Ma W; Zhang T; Pan J; Shi N; Fan Q; Wang L; Lu SH
Oncol Rep; 2014 Oct; 32(4):1601-9. PubMed ID: 25175038
[TBL] [Abstract][Full Text] [Related]
14. Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX-2, MMP-9, VEGF and CXCR4 expression in an orthotopic mouse model.
Kunnumakkara AB; Diagaradjane P; Anand P; Harikumar KB; Deorukhkar A; Gelovani J; Guha S; Krishnan S; Aggarwal BB
Int J Cancer; 2009 Nov; 125(9):2187-97. PubMed ID: 19623659
[TBL] [Abstract][Full Text] [Related]
15. Cryptotanshinone inhibits cellular proliferation of human lung cancer cells through downregulation ofIGF-1R/PI3K/Akt signaling pathway.
Zhang J; Wen G; Sun L; Yuan W; Wang R; Zeng Q; Zhang G; Yu B
Oncol Rep; 2018 Nov; 40(5):2926-2934. PubMed ID: 30106122
[TBL] [Abstract][Full Text] [Related]
16. Lentivirus-mediated RNAi knockdown of insulin-like growth factor-1 receptor inhibits the growth and invasion of hepatocellular carcinoma via down-regulating midkine expression.
Bie CQ; Liu XY; Cao MR; Huang QY; Tang HJ; Wang M; Cao GL; Yi TZ; Wu SL; Xu WJ; Tang SH
Oncotarget; 2016 Nov; 7(48):79305-79318. PubMed ID: 27813495
[TBL] [Abstract][Full Text] [Related]
17. Hedyotis diffusa Willd suppresses metastasis in 5‑fluorouracil‑resistant colorectal cancer cells by regulating the TGF‑β signaling pathway.
Lai Z; Yan Z; Chen W; Peng J; Feng J; Li Q; Jin Y; Lin J
Mol Med Rep; 2017 Nov; 16(5):7752-7758. PubMed ID: 28944846
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol Chemosensitizes TNF-β-Induced Survival of 5-FU-Treated Colorectal Cancer Cells.
Buhrmann C; Yazdi M; Popper B; Shayan P; Goel A; Aggarwal BB; Shakibaei M
Nutrients; 2018 Jul; 10(7):. PubMed ID: 30002278
[No Abstract] [Full Text] [Related]
19. Curcumin effects on cell proliferation, angiogenesis and metastasis in colorectal cancer.
Calibasi-Kocal G; Pakdemirli A; Bayrak S; Ozupek NM; Sever T; Basbinar Y; Ellidokuz H; Yigitbasi T
J BUON; 2019; 24(4):1482-1487. PubMed ID: 31646795
[TBL] [Abstract][Full Text] [Related]
20. Anti-cancer activity of amorphous curcumin preparation in patient-derived colorectal cancer organoids.
Elbadawy M; Hayashi K; Ayame H; Ishihara Y; Abugomaa A; Shibutani M; Hayashi SM; Hazama S; Takenouchi H; Nakajima M; Tsunedomi R; Suzuki N; Nagano H; Shinohara Y; Kaneda M; Yamawaki H; Usui T; Sasaki K
Biomed Pharmacother; 2021 Oct; 142():112043. PubMed ID: 34411919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
